The carboxyl-terminal di-lysine motif is essential for catalytic activity of UDP-glucuronosyltransferase 1A9

被引:2
作者
Miyauchi, Yuu [1 ,2 ]
Kurohara, Ken [1 ]
Kimura, Akane [1 ]
Esaki, Madoka [2 ]
Fujimoto, Keiko [1 ]
Hirota, Yuko [1 ]
Takechi, Shinji [2 ]
Mackenzie, Peter, I [3 ,4 ]
Ishii, Yuji [1 ,5 ]
Tanaka, Yoshitaka [1 ]
机构
[1] Kyushu Univ, Grad Sch Pharmaceut Sci, Div Pharmaceut Cell Biol, Fukuoka, Japan
[2] Sojo Univ, Fac Pharmaceut Sci, Lab Hyg Chem, Kumamoto, Japan
[3] Flinders Med Ctr, Coll Med & Publ Hlth, Clin Pharmacol, Adelaide, SA, Australia
[4] Flinders Univ S Australia, Adelaide, SA, Australia
[5] Kyushu Univ, Grad Sch Pharmaceut Sci, Lab Mol Life Sci, Fukuoka, Japan
关键词
UDP-Glucuronosyltransferase; Endoplasmic reticulum; Di-lysine motif; Secretary pathway; Cellular localization; Glucuronidation; 4-Methylumbelliferone; Oligomerization; NUCLEOTIDE SUGAR TRANSPORTER; TRANSMEMBRANE PROTEINS; GLUCURONIC ACID; EXPRESSION; SEQUENCE; RETENTION; ER; MODULATION; MICROSOMES; RETRIEVAL;
D O I
10.1016/j.dmpk.2020.07.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
UDP-Glucuronosyltransferase (UGT) is a type I membrane protein localized to the endoplasmic reticulum (ER). UGT has a di-lysine motif (KKXX/KXKXX) in its cytoplasmic domain, which is defined as an ER retention signal. However, our previous study has revealed that UGT2B7, one of the major UGT isoform in human, localizes to the ER in a manner that is independent of this motif. In this study, we focused on another UGT isoform, UGT1A9, and investigated the role of the di-lysine motif in its ER localization, glucuronidation activity, and homo-oligomer formation. Immunofluorescence microscopy indicated that the cytoplasmic domain of UGT1A9 functioned as an ER retention signal in a chimeric protein with CD4, but UGT1A9 itself could localize to the ER in a di-lysine motif-independent manner. In addition, UGT1A9 formed homo-oligomers in the absence of the motif. However, deletion of the di-lysine motif or substitution of lysines in the motif for alanines, severely impaired glucuronidation activity of UGT1A9. This is the first study that re-defines the cytoplasmic di-lysine motif of UGT as an essential peptide for retaining glucuronidation capacity. (C) 2020 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:466 / 474
页数:9
相关论文
共 39 条
  • [1] Functional UDP-xylose Transport across the Endoplasmic Reticulum/Golgi Membrane in a Chinese Hamster Ovary Cell Mutant Defective in UDP-xylose Synthase
    Bakker, Hans
    Oka, Takuji
    Ashikov, Angel
    Yadav, Ajit
    Berger, Monika
    Rana, Nadia A.
    Bai, Xiaomei
    Jigami, Yoshifumi
    Haltiwanger, Robert S.
    Esko, Jeffrey D.
    Gerardy-Schahn, Rita
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (04) : 2576 - 2583
  • [2] Modulation of the Human Glucuronosyltransferase UGT1A Pathway by Splice Isoform Polypeptides Is Mediated through Protein-Protein Interactions
    Bellemare, Judith
    Rouleau, Melanie
    Harvey, Mario
    Guillemette, Chantal
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (06) : 3600 - 3607
  • [3] SIGNAL-MEDIATED RETRIEVAL OF A MEMBRANE-PROTEIN FROM THE GOLGI TO THE ER IN YEAST
    GAYNOR, EC
    HEESEN, ST
    GRAHAM, TR
    AEBI, M
    EMR, SD
    [J]. JOURNAL OF CELL BIOLOGY, 1994, 127 (03) : 653 - 665
  • [4] Genetic diversity at the UGT1 locus is amplified by a novel 3′ alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activity
    Girard, Hugo
    Levesque, Eric
    Bellemare, Judith
    Journault, Kim
    Caillier, Bertrand
    Guillemette, Chantal
    [J]. PHARMACOGENETICS AND GENOMICS, 2007, 17 (12) : 1077 - 1089
  • [5] Pharmacogenomics of Human Uridine Diphospho-Glucuronosyltransferases and Clinical Implications
    Guillemette, C.
    Levesque, E.
    Rouleau, M.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 96 (03) : 324 - 339
  • [6] NUCLEOTIDE AND DEDUCED AMINO-ACID-SEQUENCE OF RAT-LIVER 17-BETA-HYDROXYSTEROID UDP-GLUCURONOSYLTRANSFERASE
    HARDING, D
    WILSON, SM
    JACKSON, MR
    BURCHELL, B
    GREEN, MD
    TEPHLY, TR
    [J]. NUCLEIC ACIDS RESEARCH, 1987, 15 (09) : 3936 - 3936
  • [7] Protein-protein interactions between UDP-glucuronosyltransferase isozymes in rat hepatic microsomes
    Ikushiro, S
    Emi, Y
    Iyanagi, T
    [J]. BIOCHEMISTRY, 1997, 36 (23) : 7154 - 7161
  • [8] Chemical modification of rat hepatic microsomes with N-ethylmaleimide results in inactivation of both UDP-N-acetylglucosamine-dependent stimulation of glucuronidation and UDP-glucuronic acid uptake
    Ikushiro, S
    Emi, Y
    Kimura, S
    Iyanagi, T
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1999, 1428 (2-3): : 388 - 396
  • [9] Simultaneous expression of guinea pig UDP-glucuronosyltransferase 2B21 and 2B22 in COS-7 cells enhances UDP-glucuronosyltransferase 2B21-catalyzed morphine-6-glucuronide formation
    Ishii, Y
    Miyoshi, A
    Watanabe, R
    Tsuruda, K
    Tsuda, M
    Yamaguchi-Nagamatsu, Y
    Yoshisue, K
    Tanaka, M
    Maji, D
    Ohgiya, S
    Oguri, K
    [J]. MOLECULAR PHARMACOLOGY, 2001, 60 (05) : 1040 - 1048
  • [10] Alteration of the Function of the UDP-Glucuronosyltransferase 1A Subfamily by Cytochrome P450 3A4: Different Susceptibility for UGT Isoforms and UGT1A1/7 Variants
    Ishii, Yuji
    Koba, Hiroki
    Kinoshita, Kousuke
    Oizaki, Toshiya
    Iwamoto, Yuki
    Takeda, Shuso
    Miyauchi, Yuu
    Nishimura, Yoshio
    Egoshi, Natsuki
    Taura, Futoshi
    Morimoto, Satoshi
    Ikushiro, Shin'ichi
    Nagata, Kiyoshi
    Yamazoe, Yasushi
    Mackenzie, Peter I.
    Yamada, Hideyuki
    [J]. DRUG METABOLISM AND DISPOSITION, 2014, 42 (02) : 229 - 238